14-91060376-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004755.4(RPS6KA5):​c.59A>G​(p.Asp20Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000537 in 1,507,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000056 ( 0 hom. )

Consequence

RPS6KA5
NM_004755.4 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0920
Variant links:
Genes affected
RPS6KA5 (HGNC:10434): (ribosomal protein S6 kinase A5) Enables ATP binding activity and protein serine/threonine kinase activity. Involved in several processes, including histone-serine phosphorylation; positive regulation of histone modification; and regulation of transcription, DNA-templated. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
DGLUCY (HGNC:20498): (D-glutamate cyclase) Predicted to enable D-glutamate cyclase activity. Predicted to be involved in glutamate metabolic process. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08230749).
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPS6KA5NM_004755.4 linkc.59A>G p.Asp20Gly missense_variant Exon 1 of 17 ENST00000614987.5 NP_004746.2 O75582-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPS6KA5ENST00000614987.5 linkc.59A>G p.Asp20Gly missense_variant Exon 1 of 17 1 NM_004755.4 ENSP00000479667.1 O75582-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151890
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00000565
AC:
1
AN:
176858
Hom.:
0
AF XY:
0.0000100
AC XY:
1
AN XY:
99542
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000126
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000561
AC:
76
AN:
1355426
Hom.:
0
Cov.:
31
AF XY:
0.0000565
AC XY:
38
AN XY:
672132
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000692
Gnomad4 OTH exome
AF:
0.0000548
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151890
Hom.:
0
Cov.:
32
AF XY:
0.0000539
AC XY:
4
AN XY:
74166
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000442
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000510
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000837
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 08, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.59A>G (p.D20G) alteration is located in exon 1 (coding exon 1) of the RPS6KA5 gene. This alteration results from a A to G substitution at nucleotide position 59, causing the aspartic acid (D) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.014
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.30
T;.
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.56
T;T
M_CAP
Uncertain
0.090
D
MetaRNN
Benign
0.082
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.20
N;N
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-1.1
.;N
REVEL
Benign
0.086
Sift
Uncertain
0.024
.;D
Sift4G
Uncertain
0.040
D;D
Polyphen
0.0
B;B
Vest4
0.11
MutPred
0.34
Gain of catalytic residue at G19 (P = 0);Gain of catalytic residue at G19 (P = 0);
MVP
0.47
ClinPred
0.096
T
GERP RS
0.96
Varity_R
0.11
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761932282; hg19: chr14-91526720; API